Michael J. Berendt

Director at Retension Pharmaceuticals · 2 reported transactions in 1 company · latest report Oct 13, 2026

Their trades


Retension PharmaceuticalsRTSN	Converted — · 2,640 shares	Oct 13, 2026
Retension PharmaceuticalsRTSN	Converted — · 4,026 shares	Oct 13, 2026

Oct 13, 2026 · RTSN

2,640

Oct 13, 2026 · RTSN

4,026

2 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Director at Retension Pharmaceuticals · 2 reported transactions in 1 company · latest report Oct 13, 2026


Retension PharmaceuticalsRTSN	Converted — · 2,640 shares	Oct 13, 2026
Retension PharmaceuticalsRTSN	Converted — · 4,026 shares	Oct 13, 2026

Oct 13, 2026 · RTSN

2,640

Oct 13, 2026 · RTSN

4,026

2 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.